Literature DB >> 20677925

The role of Treg cells and FoxP3 expression in immunity of β-thalassemia major AND β-thalassemia trait patients.

Gunseli Bozdogan1, Ela Erdem, Gulderen Yanikkaya Demirel, Yildiz Yildirmak.   

Abstract

There is increased susceptibility to infections in β-thalassemia. Changes in T- and B-lymphocyte subsets and functions, defective chemotaxis, and phagocytosis of neutrophils and macrophages have been described in these patients. Regulatory T cells (Treg cells) play a crucial role in the maintenance of immunological self-tolerance. The FOXP3 gene is specifically expressed on Treg cells. Increased antigenic stimuli due to repeated blood transfusions might change the Treg cells and FOXP3 percentage in β-thalassemia. Immune functions of peripheral blood lymphocytes, percentage of Treg cells (defined as CD4(+)CD25(+)FoxP3(+)) were evaluated in 30 β-thalassemia major, 30 β-thalassemia trait, and 20 healthy children. Percentage of CD4(+)CD45RA(+) cells were increased in β-thalassemia trait compared to both β-thalassemia major and controls, whereas percentage of CD4(+)CD45RO(+) cells were higher in β-thalassemia major and trait patient compared to controls. Percentages of CD4(+)CD25(bright) and CD4(+)CD25(+)FoxP3(+) Treg cells were increased only in β-thalassemia major patients compared to controls (P = .001 and P = .0001, respectively). T lymphocytes express activated phenotype both in β-thalassemia major and trait patients. However, only in β-thalassemia major patients who were exposed to chronic antigenic stimulus as a result of repeated blood transfusions was an increase observed in Treg cells, which might suppress immune activation status.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677925     DOI: 10.3109/08880018.2010.503334

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

1.  Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia.

Authors:  Weili Bao; Hui Zhong; Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

2.  Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging.

Authors:  Batoul Pourgheysari; Leila Karimi; Raihaneh Bagheri; Soleiman Kheiri
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-07       Impact factor: 0.900

3.  Alteration in Leukocyte Subsets and Expressions of FcγR and Complement Receptors among Female Ragpickers in Eastern India.

Authors:  Nandan K Mondal; Shabana Siddique; Madhuchanda Banerjee; Sanghita Roychoudhury; Sayali Mukherjee; Mark S Slaughter; Twisha Lahiri; Manas R Ray
Journal:  Saf Health Work       Date:  2016-12-09

4.  A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from beta-Thalassemia Major: A Pilot Study.

Authors:  Afshan Sumera; Nur Diana Anuar; Ammu Kutty Radhakrishnan; Hishamshah Ibrahim; Nurul H Rutt; Nur Hafiza Ismail; Ti-Myen Tan; Abdul Aziz Baba
Journal:  Biomedicines       Date:  2020-04-26

5.  Higher Hospitalization Rate for Lower Airway Infection in Transfusion-Naïve Thalassemia Children.

Authors:  Ti-An Tsai; Chang-Ku Tsai; Yao-Hsu Yang; Zon-Min Lee; Jiunn-Ming Sheen; Yi-Chen Lee; Chih-Min Tsai; Chih-Cheng Chen; Chih-Hao Chang; Chen-Kuang Niu; Hong-Ren Yu
Journal:  Front Pediatr       Date:  2020-11-24       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.